OBJECTIVE: The primary objective of the trial is to compare survival to hospital discharge with modified Rankin score (MRS) < or =3 between a strategy that prioritizes a specified period of CPR before rhythm analysis (Analyze Later) versus a strategy of minimal CPR followed by early rhythm analysis (Analyze Early) in patients with out-of-hospital cardiac arrest. METHODS: Design-Cluster randomized trial with cluster units defined by geographic region, or monitor/defibrillator machine. Population-Adults treated by emergency medical service (EMS) providers for non-traumatic out-of-hospital cardiac arrest not witnessed by EMS. Setting-EMS systems participating in the Resuscitation Outcomes Consortium and agreeing to cluster randomization to the Analyze Later versus Analyze Early intervention in a crossover fashion. Sample size-Based on a two-sided significance level of 0.05, a maximum of 13,239 evaluable patients will allow statistical power of 0.996 to detect a hypothesized improvement in the probability of survival to discharge with MRS < or =3 rate from 5.41% after Analyze Early to 7.45% after Analyze Later (2.04% absolute increase in primary outcome). CONCLUSION: If this trial demonstrates a significant improvement in survival with a strategy of Analyze Later, it is estimated that 4000 premature deaths from cardiac arrest would be averted annually in North America alone.
RCT Entities:
OBJECTIVE: The primary objective of the trial is to compare survival to hospital discharge with modified Rankin score (MRS) < or =3 between a strategy that prioritizes a specified period of CPR before rhythm analysis (Analyze Later) versus a strategy of minimal CPR followed by early rhythm analysis (Analyze Early) in patients with out-of-hospital cardiac arrest. METHODS: Design-Cluster randomized trial with cluster units defined by geographic region, or monitor/defibrillator machine. Population-Adults treated by emergency medical service (EMS) providers for non-traumatic out-of-hospital cardiac arrest not witnessed by EMS. Setting-EMS systems participating in the Resuscitation Outcomes Consortium and agreeing to cluster randomization to the Analyze Later versus Analyze Early intervention in a crossover fashion. Sample size-Based on a two-sided significance level of 0.05, a maximum of 13,239 evaluable patients will allow statistical power of 0.996 to detect a hypothesized improvement in the probability of survival to discharge with MRS < or =3 rate from 5.41% after Analyze Early to 7.45% after Analyze Later (2.04% absolute increase in primary outcome). CONCLUSION: If this trial demonstrates a significant improvement in survival with a strategy of Analyze Later, it is estimated that 4000 premature deaths from cardiac arrest would be averted annually in North America alone.
Authors: M L Weisfeldt; R E Kerber; R P McGoldrick; A J Moss; G Nichol; J P Ornato; D G Palmer; B Riegel; S C Smith Journal: Circulation Date: 1995-11-01 Impact factor: 29.690
Authors: I G Stiell; G A Wells; B J Field; D W Spaite; V J De Maio; R Ward; D P Munkley; M B Lyver; L G Luinstra; T Campeau; J Maloney; E Dagnone Journal: JAMA Date: 1999-04-07 Impact factor: 56.272
Authors: Blair L Bigham; Kent Koprowicz; Tom Rea; Paul Dorian; Tom P Aufderheide; Daniel P Davis; Judy Powell; Laurie J Morrison Journal: Resuscitation Date: 2011-03-31 Impact factor: 5.262
Authors: Robert H Schmicker; Brian G Leroux; Gena K Sears; Ian Stiell; Laurie J Morrison; Tom P Aufderheide; Ray Fowler; Rusty Lowe; Stanley Morrow; Ed Plumlee; Sheldon Cheskes Journal: Clin Trials Date: 2012-03-23 Impact factor: 2.486
Authors: Ian R Drennan; Erin Case; P Richard Verbeek; Joshua C Reynolds; Zachary D Goldberger; Jamie Jasti; Mark Charleston; Heather Herren; Ahamed H Idris; Paul R Leslie; Michael A Austin; Yan Xiong; Robert H Schmicker; Laurie J Morrison Journal: Resuscitation Date: 2016-12-05 Impact factor: 5.262
Authors: Thomas Rea; David Prince; Laurie Morrison; Clifton Callaway; Tom Aufderheide; Mohamed Daya; Ian Stiell; Jim Christenson; Judy Powell; Craig Warden; Lois van Ottingham; Peter Kudenchuk; Myron Weisfeldt Journal: Ann Emerg Med Date: 2014-02-13 Impact factor: 5.721
Authors: Steven C Brooks; Robert H Schmicker; Sheldon Cheskes; Jim Christenson; Alan Craig; Mohamud Daya; Peter J Kudenchuk; Graham Nichol; Dana Zive; Laurie J Morrison Journal: Resuscitation Date: 2017-06-15 Impact factor: 5.262
Authors: V Wenzel; S G Russo; H R Arntz; J Bahr; M A Baubin; B W Böttiger; B Dirks; U Kreimeier; M Fries; C Eich Journal: Anaesthesist Date: 2010-12 Impact factor: 1.041
Authors: Myron L Weisfeldt; Colleen M Sitlani; Joseph P Ornato; Thomas Rea; Tom P Aufderheide; Daniel Davis; Jonathan Dreyer; Erik P Hess; Jonathan Jui; Justin Maloney; George Sopko; Judy Powell; Graham Nichol; Laurie J Morrison Journal: J Am Coll Cardiol Date: 2010-04-20 Impact factor: 24.094
Authors: Henry E Wang; David K Prince; Shannon W Stephens; Heather Herren; Mohamud Daya; Neal Richmond; Jestin Carlson; Craig Warden; M Riccardo Colella; Ashley Brienza; Tom P Aufderheide; Ahamed H Idris; Robert Schmicker; Susanne May; Graham Nichol Journal: Resuscitation Date: 2016-02-02 Impact factor: 5.262
Authors: Steven M Bradley; Erin E Gabriel; Tom P Aufderheide; Roxy Barnes; Jim Christenson; Daniel P Davis; Ian G Stiell; Graham Nichol Journal: Resuscitation Date: 2009-12-06 Impact factor: 5.262
Authors: Sheldon Cheskes; Robert H Schmicker; P Richard Verbeek; David D Salcido; Siobhan P Brown; Steven Brooks; James J Menegazzi; Christian Vaillancourt; Judy Powell; Susanne May; Robert A Berg; Rebecca Sell; Ahamed Idris; Mike Kampp; Terri Schmidt; Jim Christenson Journal: Resuscitation Date: 2013-10-25 Impact factor: 5.262